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Abstract
Background: Induction of stem cell differentiation toward functional hepatocytes is hampered by
lack of knowledge of the hepatocyte differentiation processes. The overall objective of this project
is to characterize key stages in the hepatocyte differentiation process.
Results: We established a mouse embryonic stem (mES) cell culture system which exhibited
changes in gene expression profiles similar to those observed in the development of endodermal
and hepatocyte-lineage cells previously described in the normal mouse embryo. Transgenic mES
cells were established that permitted isolation of enriched hepatocyte-lineage populations. This
approach has isolated mES-derived hepatocyte-lineage cells that express several markers of mature
hepatocytes including albumin, glucose-6-phosphatase, tyrosine aminotransferase, cytochrome
P450-3a, phosphoenolpyruvate carboxykinase and tryptophan 2,3-dioxygenase. In addition, our
results show that the up-regulation of the expression levels of hepatocyte nuclear factor-3α, -4α,
-6, and CCAAT-enhancer binding protein-β might be critical for passage into late-stage
differentiation towards functional hepatocytes. These data present important steps for definition
of regulatory phenomena that direct specific cell fate determination.
Conclusion: The mES cell culture system generated in this study provides a model for studying
transition between stages of the hepatocyte development and has significant potential value for
studying the molecular basis of hepatocyte differentiation in vitro.
Background
Liver failure is one of the major causes of morbidity and
mortality worldwide [1]. The only effective treatment so
far for acute and chronic liver failure is liver transplanta-
tion [2]. However, liver transplantation has several limita-
tions, especially, the shortage of organ donors. During the
last decade, hepatocyte transplantation therapy has
emerged as an attractive alternative treatment for end-
stage liver disease [3-5]. To enhance the potential for this
approach, hepatocyte transplantation therapy requires a
renewable cell source of functional hepatocytes in vitro.
One of the most promising potential sources of functional
hepatocytes is from directed embryonic stem (ES) cell dif-
ferentiation.
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At present, lack of detailed knowledge of the hepatocyte
differentiation events restricts this potential. Several
groups have reported that mouse embryonic stem (mES)
cells can differentiate towards hepatocyte-lineage, based
on the expression of several hepatocyte-lineage marker
genes, but the underlying mechanisms that steer the
induction of stem cell differentiation toward functional
hepatocytes is poorly characterized [6-9]. Hepatocyte-lin-
eage marker genes have been categorized into four groups,
representing stages in the potential sequence of molecular
events of hepatocyte differentiation. The first group are
endodermal markers (expressed in endodermal cells, the
precursor of all hepatocyte-lineage cells) including α-feto-
protein (AFP) and hepatocyte nuclear factor-3β (HNF-3β)
[10]. The second group are fetal hepatocyte markers
(expressed in fetal hepatocytes) including albumin
[10,11]. The third group are perinatal hepatocyte markers
(expressed in hepatocytes around the time of birth)
including glucose-6-phosphatase (G6Pase) and tyrosine
aminotransferase (TAT) [12]. The fourth group are post-
natal (mature) hepatocyte markers (expressed in hepato-
cytes in the period following birth) including cytochrome
P450-3a (Cyp3a), phosphoenolpyruvate carboxykinase
(Pepck) and tryptophan 2,3-dioxygenase (TDO) [13,14].
The expression of hepatocyte-lineage marker genes is pri-
marily regulated at transcriptional level [15,16]. Promot-
ers of hepatocyte-lineage marker genes contain
combinations of DNA regulatory elements for binding
liver-enriched transcription factors (LETFs) [15,16].
Despite the importance of LETFs in regulation of expres-
sion of hepatocyte-lineage marker genes, as yet, few stud-
ies have examined the profile and sequence of expression
of LETFs in the differentiation of ES cells.
The overall aim of this study was to determine the expres-
sion of LETFs during differentiation of ES cells toward
hepatocyte-lineages  in vitro. Our study had two linked
stages. Firstly, we developed culture conditions that
enhanced differentiation towards a hepatic phenotype.
Secondly, to permit a more detailed characterization of
the underlying regulatory mechanisms that define mES-
derived hepatocyte-lineage cells, transgenic mES cell lines
expressing green fluorescent protein (GFP), under the
control of an albumin promoter/enhancer element were
created and used to purify hepatocyte-lineage cells by flu-
orescent-activated cell sorting (FACS). The pattern of
expression of hepatocyte-lineage marker and LETF genes
was examined in populations of cells generated from
FACS.
Results
HIM exhibits enhanced potential for differentiation of 
mES cells toward hepatocyte-lineages
RT-PCR analysis of differentiation marker gene expression
indicated that culturing of cells in hepatocyte inducing
medium (HIM) supported mES cell differentiation
through to postnatal stage of hepatocyte development.
Populations generated from culture in non-differentiated
ES medium (NDESM) without leukemia inhibitory factor
(LIF) expressed endodermal marker genes (AFP and HNF-
3β) but failed to show the expression of fetal (albumin),
perinatal (G6Pase and TAT) or postnatal (Cyp3a and
TDO) hepatocyte marker genes throughout the time
course of culture (up to day 23) (Figure 1A). In contrast,
mES cell populations generated from culture in HIM
showed expression of all hepatocyte-lineage marker gene
examined including postnatal hepatocyte markers (Figure
1B). In addition, the hepatocyte marker genes in HIM cul-
ture were expressed in an order (endodermal, fetal, peri-
natal, postnatal) similar to that observed in the
development of the normal mouse embryo [6,17]. How-
RT-PCR analysis for hepatocyte-lineage marker genes of mES  cell populations generated from NDESM and HIM cultures Figure 1
RT-PCR analysis for hepatocyte-lineage marker 
genes of mES cell populations generated from 
NDESM and HIM cultures. The figure shows agarose gel 
electrophoresis of RT-PCR analysis for HNF-3b, AFP, Albu-
min, TAT, G6Pase, Cyp3a, Pepck and TDO gene expression 
from mES cell population generated from NDESM culture 
(A) or HIM culture (B) over periods of culture [HNF-3b = 
hepatocyte nuclear factor-3β, AFP = α-fetoprotein, ALB = 
albumin, Cyp3a = cytochrome P450-3a, G6Pase = glucose-6-
phosphatase, Pepck = phosphoenolpyruvate carboxykinase, 
Pou5f1 = POU domain class5 transcription factor 1, TAT = 
tyrosine aminotransferase, TDO = tryptophan 2,3-dioxygen-
ase, Liver = intact mouse liver. EB = mES cell populations 
generated from NDESM culture, ES = non-differentiated mES 
cells, N = mES cell populations generated from HIM culture, 
Number indicate days in culture (as described in materials & 
methods)].BMC Molecular Biology 2009, 10:35 http://www.biomedcentral.com/1471-2199/10/35
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ever, the expression of Pou5f1 was observed throughout
the culture period implying that some non-differentiated
mES cells were present even at the end of the culture (Fig-
ure 1).
Flow cytometry fractionation of hepatocyte-lineage cells 
from differentiated mES cell populations
Although culture in HIM enhanced the derivation of cells
of hepatocyte-lineage, it was clear that mES cell popula-
tions generated from this culture condition contained
mixed cell types. Most mES cells (under light microscopy)
exhibited circular-shaped cell morphology with a diame-
ter about 10 μm but some (a minority) exhibited epithe-
lial-like morphology (polygonal-shaped by microscopy,
diameter about 15 μm, data not shown). The observed
heterogeneity limited the interpretation of changes in
gene expression in terms of differentiation toward hepato-
cyte-lineage. Consequently, linked to HIM culture, we iso-
lated hepatocyte-lineage cells from the mixed population
by fluorescence with EGFP expressed from a reporter con-
struct under the control of a hepatocyte-specific (albu-
min) promoter/enhancer element.
After mES cell transfection, 66 clonal transfectants (pALB-
EGFP/ES) were obtained and four randomly selected
pALB-EGFP/ES cell lines were cultured in HIM and the
percentages of GFP-expressing cells (considered here to be
hepatocyte-lineage cells) were determined by flow cytom-
etry. One cell line, A.9, expressed a higher percentage of
GFP-expressing cells than the others upon differentiation
and this cell line was selected for a more detail analysis of
mES cell differentiation using FACS. GFP-expressing cells
were purified from the A.9 populations, after 21 days
(A.9.2+) and 23 days (A.9.3+) of culture by FACS and
GFP-negative cells (considered here to be non-hepatocyte-
lineage cells) were also isolated at each stage of culture
(A.9.2- and A.9.3-, respectively) (Figure 2B–C). The per-
centage of GFP-expressing cells was increased from 17.81
± 3.4% at culture day 21 to 23.74 ± 2.8% at culture day 23
(Figure 2B–C). The sorted GFP-expressing cells homoge-
neously exhibited epithelial-like morphology (polygonal-
shaped with refractive cell border, diameter about 15 μm)
(Figure 2D). Unsorted cells from cultured cell line A.9
were harvested at 23 days of culture (N23) as a further
comparator. RT-PCR indicated that N23 expressed all the
hepatocyte-lineage marker genes including HNF-3β, AFP,
albumin, TAT, G6Pase, Cyp3a, Pepck and TDO (Figure 3).
All hepatocyte-lineage marker genes detected in N23 were
also detected in purified GFP-expressing cells (A.9.2+ and
A.9.3+). In addition, the expression of Pou5f1 was absent
in both A.9.2+ and A.9.3+ indicating that the contami-
nated non-differentiated mES cells were separated from
the populations after FACS (Figure 3). The A.9.3- popula-
tion expressed several hepatocyte-lineage marker genes
(HNF-3β, AFP, albumin, TAT) but crucially did not
express perinatal or postnatal marker genes (G6Pase,
Pepck, Cyp3a and TDO) (Figure 3). These data indicate
that the A.9 cell line cultured in HIM could generate cells
with the genetic characteristics of mature hepatocytes,
which by sorting allow for subsequent definition of the
relationships between cell line development and tran-
scriptional regulatory events.
As a further step towards understanding regulatory events
linked to mature hepatocyte differentiation processes, the
expression of cytochrome P450-3a (Cyp3a) and glucose-
6-phosphatase (G6Pase) was measured in A.9.2+ and
A9.3+ cells by quantitative real-time PCR (qRT-PCR).
Expression of Cyp3a and G6Pase increased from 21 to 23
days of culture in the GFP-expressing populations towards
the level found in intact mouse liver (about 2.4 and
15.4% of the intact liver value, respectively) (Figure 4).
Expression of liver-enriched transcription factors during 
mES cell differentiation
Having defined a method for enhancement of differentia-
tion towards hepatocyte-lineage (culture in HIM) and a
means to enrich hepatocyte-lineage cells, we sought to
examine how control of differentiation towards hepato-
cyte lineage was related to the pattern of expression of the
network of LETFs. To this end we determined expression
of 7 LETFs at mRNA level throughout mES culture in HIM
and in populations separated on the basis of pALB-EGFP
expression (Figure 5)
Expression of HNF-1β in mES cell populations was great-
est (about 69% of intact mouse liver value) at day 4 of cul-
ture and remained constant over a further 10 days before
decreasing (to about 8% of intact mouse liver value) (Fig-
ure 5A). The expression of HNF-3β increased over the first
10 days of culture and reached its highest value (about
48% of intact mouse liver value) at day 14 before decreas-
ing (to about 8% of intact mouse liver value) (Figure 5B).
HNF-3α and C/EBP-β exhibited a pattern of expression
that was similar to that of HNF-3β, increasing over the
first 8 days of culture to reach their highest values (about
8% and 21% of intact mouse liver value, respectively) at
day 8 before decreasing (to about 2% and 4% of intact
mouse liver value, respectively) (Figures 5C–D).
Although the expression of HNF-4α and HNF-6 also
increased over the first 8 days of culture, to reach its great-
est expression at that time (about 1% and 2% of intact
mouse liver value, respectively) the expression of these
two transcription factors remained unchanged from that
point until the end of culture (Figures 5E–F). In contrast
to all other LETF genes examined, C/EBP-α mRNA could
not be detected at any stage of culture (despite ready
detection in samples from intact mouse liver, data not
shown).BMC Molecular Biology 2009, 10:35 http://www.biomedcentral.com/1471-2199/10/35
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GFP-expressing cell populations were isolated from A.9
cells cultured in HIM for 21 (A.9.2+) and 23 (A.9.3+)
days. It was notable that the expression of all LETFs exam-
ined increased progressively from 21 to 23 days of culture
for GFP-expressing populations (Figures 5A–F). In partic-
ular, the expression of HNF-3α and C/EBP-β in the A.9.3+
population reached values similar to those observed for
intact mouse liver (Figures 5C–D). In contrast to HNF-3α
and C/EBP-β, the expression of HNF-4α and HNF-6 in the
A.9.3+ population was still much lower than that of intact
mouse liver (about 4% of intact mouse liver value, in each
Fluorescent-activated cell sorting (FACS) of GFP-expressing cells and GFP-negative cells from cultured A.9 populations Figure 2
Fluorescent-activated cell sorting (FACS) of GFP-expressing cells and GFP-negative cells from cultured A.9 
populations. The figure shows the percentage of GFP-expressing cells in cultured A.9 populations at culture day 21(B) and 
day 23(C). Non-transfected mES cell population (ES-WT) serve as a negative control to determine the intrinsic fluorescent 
intensity of the cultured mES cell populations and to define positive area R2 (A). GFP-expressing cells from R2 regions and 
GFP-negative cells from R1 regions of cultured A.9 populations (B-C) were sorted using a Becton Dickinson FACstar flow 
cytometer and CellQuest® software. Data are presented as means ± SEM. (D) show the morphology of sorted GFP-expressing 
cells [A.9.2+ = GFP-expressing cells purified from cultured A.9 population at culture day 21, A.9.2- = GFP-negative cells puri-
fied from cultured A.9 population at culture day 21, A.9.3+ = GFP-expressing cells purified from cultured A.9 population at cul-
ture day 23, A.9.3- = GFP-negative cells purified from cultured A.9 population at culture day 23, R1 = GFP-negative cells, R2 = 
GFP-expressing cells].BMC Molecular Biology 2009, 10:35 http://www.biomedcentral.com/1471-2199/10/35
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case) (Figures 5E–F). Again, C/EBP-α mRNA expression
was undetectable (data not shown).
For GFP-negative cell populations isolated after 21 and 23
days of culture (A.9.2- and A.9.3-), the expression of HNF-
1β, HNF-3β, HNF-6 and C/EBP-β was similar to that of
non-differentiated mES cells (N0) (Figures 5A, B, D, F)
whereas the expression of HNF-3α and HNF-4α were sim-
ilar to that of the unsorted albumin-negative cultured
mES cell population (N8) (Figure 5C, E).
Discussion
The ability of ES cells to differentiate to various cells of
ectoderm, mesoderm and endoderm lineages in vitro
offers a promising system to study cell differentiation
processes that opens the potential for cell replacement
therapy. In this study, we categorized the hepatocyte-line-
age marker genes into four groups (endodermal, fetal
hepatocyte, perinatal hepatocyte and postnatal hepato-
cyte) according to the expression pattern during the devel-
opment of mouse liver [10-14,18,19] to facilitate the
identification of the corresponding developmental state
of the differentiated mES cells. We demonstrated that
even though the differentiated EBs can generate endoder-
mal cells (precursor of all hepatocyte-lineages), these
mES-derived endodermal cells cannot proceed past a spe-
cific "check point" to generate hepatocyte-like cells
(which express fetal, perinatal and postnatal hepatocyte
RT-PCR analysis for hepatocyte-lineage marker genes in  pALB-EGFP/ES cell line 9 (A.9) cultures Figure 3
RT-PCR analysis for hepatocyte-lineage marker 
genes in pALB-EGFP/ES cell line 9 (A.9) cultures. The 
figure shows agarose gel electrophoresis of RT-PCR analysis 
for HNF-3β, AFP, Albumin, TAT, G6Pase, Cyp3a, TDO and 
Pepck gene expression in pALB-EGFP/ES cell line 9 (A.9) cul-
tured in HIM [N = mES cell populations generated from HIM 
culture, Number indicate days in culture (as described in 
materials & methods), A.9.2+ = GFP-expressing cells purified 
from cultured A.9 population at culture day 21, A.9.3+ = 
GFP-expressing cells purified from cultured A.9 population at 
culture day 23, A.9.3- = GFP-negative cells purified from cul-
tured A.9 population at culture day 23, HNF-3b = hepatocyte 
nuclear factor-3β, AFP = α-fetoprotein, Cyp3a = cytochrome 
P450-3a, G6Pase = glucose-6-phosphatase, Pepck = phos-
phoenolpyruvate carboxykinase, Pou5f1 = POU domain 
class5 transcription factor 1, TAT = tyrosine aminotrans-
ferase, TDO = tryptophan 2,3-dioxygenase, Liver = intact 
mouse liver].
The expression of Cyp3a and G6Pase genes in A.9.2+ and A.9.3+ populations Figure 4
The expression of Cyp3a and G6Pase genes in A.9.2+ and A.9.3+ populations. The figure shows the expression level 
of Cyp3a (A) and G6Pase (B) genes in A.9.2+, A.9.3+ populations. Data are presented as means ± SEM of three independent 
experiments. (A.9.2+ = GFP-expressing cells purified from cultured A.9 population at culture day 21, A.9.3+ = GFP-expressing 
cells purified from cultured A.9 population at culture day 23, Cyp3a = cytochrome P450-3a, G6Pase = glucose-6-phosphatase, 
Liver = intact mouse liver). [*P < 0.05 vs. A.9.2+].BMC Molecular Biology 2009, 10:35 http://www.biomedcentral.com/1471-2199/10/35
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marker genes) without the supplementation of some
undetermined critical factors (Figure 6).
Several previously published papers have reported that
mES cell-derived EBs expressed ALB and TAT genes, when
cultured in same medium as our control condition,
NDESM [9,20,21]. There are several potential reasons that
would explain the apparent discrepancy. Firstly, the mES
cell lines used in this study is different from those used in
previous publications. It is well known that different mES
cell lines have varied differentiation capacity even though
cultured in the same conditions [22-24]. Secondly, unlike
previous studies, we did not use the "hanging drop
method" for generating EBs and this is an important factor
which might contribute to the differences in the experi-
mental results.
This is the first report, to our knowledge, to demonstrate
that a relatively simple medium, supplemented with insu-
lin and dexamethasone and no other growth factors, can
support induction of cultured mES cells towards endoder-
mal and hepatocyte-lineage cells in a pattern similar to
that of mouse embryos [6,17] (Figure 6). Other workers
have reported a need to make sequential additions of sev-
eral growth factors to mimic the expression profile of
hepatocyte-lineage markers in cultured mES cells popula-
The expression of liver-enriched transcription factor genes in pALB-EGFP/ES cell line 9 (A.9) cultures Figure 5
The expression of liver-enriched transcription factor genes in pALB-EGFP/ES cell line 9 (A.9) cultures. The fig-
ure shows the expression levels of HNF-1b (A); HNF-3b (B); HNF-3a (C); C/EBP-b (D); HNF-4a (E) and HNF-6 (F) genes in 
pALB-EGFP/ES cell line 9 (A.9) cultured in HIM. Data are presented as means ± SEM of three independent experiments (A.9.2+ 
= GFP-expressing cells purified from cultured A.9 population at culture day 21, A.9.3+ = GFP-expressing cells purified from 
cultured A.9 population at culture day 23, A.9.3- = GFP-negative cells purified from cultured A.9 population at culture day 23, 
HNF-1b, HNF-3b, HNF-3a, HNF-4a, HNF-6 = hepatocyte nuclear factor-1β, -3β, -3α, -4α and 6, respectively; C/EBP-b = 
CCAAT-enhancer binding protein-β, Liver = intact mouse liver). [*P < 0.05 vs. N populations].BMC Molecular Biology 2009, 10:35 http://www.biomedcentral.com/1471-2199/10/35
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tions but in our system this was unnecessary [6,21,25-27].
However, the percentage of albumin-expressing cells gen-
erated from HIM culture was still lower than those
reported using the sequential addition of growth factors.
This implies that the sequential addition of growth factors
may improve the differentiation efficiency even through
they are not critical for the induction of the expression of
those hepatocyte-lineage genes.
It also appeared that albumin-expressing cells were also
detected in GFP-negative cell populations (A.9.2- and
A.9.3-) as determined by RT-PCR. This might arise
through two reasons. Firstly, the albumin promoter/
enhancer region used in this study (Alb-p/e) contained
only parts of the whole physiological albumin promoter.
Thus, it is possible that the GFP-negative, albumin-
expressing cells may produce albumin-mRNA under con-
trol of the albumin promoter regions which are located
outside Alb-p/e. Secondly, it is also possible that the trans-
fected Alb-p/e might be inactivated in some albumin-
expressing A.9 cells. Such events can account for the lack
of GFP-expression in albumin-expressing cells.
We have shown that up-regulation of the expression of
HNF-3α, HNF-4α, HNF-6, and C/EBP-β was specific to
the hepatocyte-lineage cells in the heterogeneous cultured
mES cell populations (Figure 5C–F). By implication, this
suggests that these transcription factors might be required
for the initiation of cell progression towards full expres-
sion of hepatocyte-lineage marker genes in mES-derived
hepatocyte-like cells. In contrast, the expression of HNF-
1β and HNF-3β in the mES-derived hepatocyte-lineage
cells (which expressed fetal, perinatal and postnatal hepa-
tocyte markers) was not significantly different from that of
albumin-negative cell populations (N4, N8, which
expressed only endodermal marker genes). These data
suggest that although HNF-1β and HNF-3β are required
for expression of endodermal marker genes (AFP) they
might not be required for the expression of fetal, perinatal
and postnatal hepatocyte marker genes (albumin, TAT,
G6Pase, Cyp3a, Pepck and TDO) (Figure 6).
Others have reported that expression of HNF-1β and
HNF-3β was increased when definitive endoderm (the
precursor of all hepatocyte lineage cells) was generated
Progression of cultured mES cells towards hepatocyte-lineages Figure 6
Progression of cultured mES cells towards hepatocyte-lineages. The figure shows the progression of mES cells in 
NDESM and HIM cultures along the hepatocyte-lineages. [AFP = α-fetoprotein, HNF-1b, HNF-3b, HNF-3a, HNF-4a, HNF-6 = 
hepatocyte nuclear factor-1β, -3β, -3α, -4α and 6, respectively; C/EBP-a, C/EBP-b = CCAAT-enhancer binding protein-α, -β, 
respectively; TAT = tyrosine aminotransferase, Cyp3a = cytochrome P450-3a, Pepck = phosphoenolpyruvate carboxykinase, 
TDO = tryptophan 2,3-dioxygenase, (low) = the expression level is low].BMC Molecular Biology 2009, 10:35 http://www.biomedcentral.com/1471-2199/10/35
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and then decreased (in case of HNF-1β) or remained con-
stant (in case of HNF-3β) during the remainder of liver
development [28].
Although expression of HNF-3α and C/EBP-β in the
A.9.3+ population (which is the highest of all cultured
mES cell populations generated in this study) was similar
to that of intact mouse liver, the expression of HNF-4α
and HNF-6 was 40-fold less than that of intact liver. The
expression of C/EBP-α, which is considered to be involved
in perinatal and postnatal stages of hepatocyte differenti-
ation processes [16,29-31], was not detected in any cul-
tured mES cells populations in this study. Moreover,
although A.9.2+ and A.9.3+ mES-derived cells expressed
all hepatocyte-lineage marker genes examined, the expres-
sion of perinatal and postnatal hepatocyte marker genes
(G6Pase and Cyp3a) was much less than that of intact
mouse liver (Figure 4). The lack of the significant expres-
sion of "late phase" transcription factors such as C/EBP-α
(and HNF-4α and HNF-6) implies a regulatory point of
key significance towards the transition to expression peri-
natal and postnatal hepatocyte marker genes (G6Pase and
Cyp3a) in the mES-derived hepatocyte-lineage cell popu-
lations. This interpretation agrees with reports that C/EBP-
α -/- mice died within 8 hours after birth due to hypogly-
cemia caused by low expression of several glucose metab-
olism enzymes including G6Pase (perinatal hepatocyte
marker gene) and Pepck (postnatal hepatocyte marker
gene) [30,31].
Conclusion
We have provided a detailed analysis of the sequential and
coordinated changes in key transcription factor gene
expression in an in vitro model of hepatocyte differentia-
tion (Figure 6). These data indicate that the regulation of
expression of late phase transcription factors is critical for
Table 1: Target genes, primer sequences, product sizes and primer-specific annealing temperatures (AT) used for PCR
Target genes Sequences of primer (5'-3') Product sizes (kB) AT (°C)
AFP (NM_007423.3)
Forward cactgctgcaactcttcgta 300 55
Reverse ctttggaccctcttctgtga
Albumin (NM_009654.1)
Forward tgaactggctgactgctgtg 718 55
Reverse catccttggcctcagcatag
HNF-3β (NM_010446.1)
Forward actggagcagctactacg 169 55
Reverse cccacataggatgacatg
Cyp3a (NM_007818.2)
Forward tacagcatggatgtgatca 380 55
Reverse tcatacccagcaaaaataaa
G6Pase (NM_008061.2)
Forward caggactggttcatcctt 210 55
Reverse gttgctgtagtagtcggt
Pepck (NM_011044.1)
Forward tctgccaaggtcatccagg 290 60
Reverse gttttggggatgggcactg
TAT (NM_146214.1)
Forward accttcaatcccatccga 206 57
Reverse tcccgactggataggta
TDO (NM_019911.2)
Forward agagccagcaaaggaggac 500 55
Reverse ctgtctgctcctgctctgat
Pou5f1 (NM_013633.2)
Forward ggcgttctctttggaaaggtgttc 313 55
Reverse ctcgaaccacatccttctct
Abbreviation: HNF-3b = hepatocyte nuclear factor-3β, AFP = α-fetoprotein, Cyp3a = cytochrome P450-3a, G6Pase = glucose-6-phosphatase, 
Pepck = phosphoenolpyruvate carboxykinase, Pou5f1 = POU domain class5 transcription factor 1, TAT = tyrosine aminotransferase, TDO = 
tryptophan 2,3-dioxygenase, GAPDH = glyceraldehyde-3-phosphate dehydrogenase.BMC Molecular Biology 2009, 10:35 http://www.biomedcentral.com/1471-2199/10/35
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optimization of differentiation of ES cells towards a full
hepatocyte phenotype in vitro. However, the direct evi-
dence for any causal relationship between specific tran-
scription factors and the differentiation would only arise
through further experiments involving over-expression
and/or knockdown of specific transcription factors. None-
theless, the system we have developed and the molecular
characterization of the transcription factor (and target
gene) profiles offer a critical model for direct examination
of molecular determinants of hepatocyte differentiation
control. That information will not only develop further
understanding of cell differentiation processes but will aid
researchers in examination of the potential for use of
human ES cells in the generation of donor hepatocytes for
cell replacement therapies.
Methods
Culture of mES cells
Mouse embryonic stem (mES) cells [E14, a generous gift
from Dr. Christopher Ward, The University of Manchester
[23]] were maintained as described previously [6]. Briefly,
non-differentiated mES cells were cultured on a gelatin-
coated flask [prepared by coating a tissue culture flask
with 0.1% (w/v) Type A gelatin from porcine skin (Sigma,
UK)] in LIF-NDESM which is Knockout™ Dulbecco's
modified Eagle's medium (Gibco, UK) supplemented
with 10% (v/v) fetal bovine serum (Cambrex, UK), 1% (v/
v) 10 mM non-essential amino acids solution (Cambrex,
UK), 1% (v/v) 200 mM L-glutamine (Cambrex, UK),
0.001% (v/v) 14.3 M β-mercaptoethanol (Sigma, UK) and
1000 unit/ml leukemia inhibitory factor (LIF, Chemicon,
UK). To induce differentiation, mES cells were removed
from gelatin-coated flasks by incubation with 0.25 mg/ml
trypsin and 0.2 mg/ml EDTA (Cambrex, UK) for 2 min-
utes, trypsinized to a single cell suspension and trans-
ferred to bacterial Petri dishes (Falcon, UK) at a
concentration of 2 × 106 cells/10 cm dish in NDESM with-
out LIF and incubated at 37°C in 5% CO2 incubator for 4
days. During this time embryoid bodies (EBs) formed. At
this stage (which was counted as culture day 0), EBs were
plated and attached to gelatin-coated flasks in non-differ-
entiating ES medium (NDESM) or hepatocyte-inducing
medium (HIM) [NDESM without LIF supplemented with
1 × 10-6 M dexamethasone (Sigma, UK), 1 × 10-8 M insulin
Table 2: Target genes, product sizes and primer sequences used for quantitative real-time PCR
Target genes Sequences of primer (5'-3') Product sizes (kB)
CEBP-α (NM_007678.2)
Forward gctttttgcacctccaccta 170
Reverse ccacaaagcccagaaaccta
CEBP-β (NM_009883.1)
Forward caagctgagcgacgagtaca 157
Reverse cagctgctccaccttcttct
HNF-1β (NM_009330.2)
Forward gacactcctcccatcctcaa 156
Reverse ctccctctgggggatattgt
HNF-3α (NM_008259.2)
Forward cagcacaagctggacttcaa 173
Reverse agcacgggtctggaatacac
HNF-3β (NM_010446.1)
Forward taagcgagctaaagggagca 176
Reverse agagaaggggtggttgaagg
HNF-4α (NM_008261.2)
Forward agaggttctgtcccagcaga 169
Reverse atccagaaggagttcgcaga
HNF-6 (NM_008262.2)
Forward ctgtgaaactcccccaggta 179
Reverse tgaaactaccgctcacgttg
GAPDH (NM_199472.1)
Forward acccagaagactgtggatgg 172
Reverse cacattgggggtaggaacac
Abbreviation: HNF = hepatocyte nuclear factor, C/EBP = CCAAT-enhancer binding protein, GAPDH = glyceraldehyde-3-phosphate dehydrogenaseBMC Molecular Biology 2009, 10:35 http://www.biomedcentral.com/1471-2199/10/35
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(Sigma, UK) and 200 mM L-glutamine (Cambrex, UK)]
and allowed to attach at 37°C in 5% CO2 incubator for 2
days. The appropriate culture medium was replaced every
24 hours.
pALB-EGFP Plasmid Construction
A plasmid was constructed with a 2,335 bp fragment of
the mouse albumin promoter/enhancer (incorporating a
region from -8.5 to -10.4 kb of the albumin enhancer
fused to the -0.3 kb minimal albumin promoter
sequences, a generous gift from Professor Richard
Palmiter, University of Washington [32], cloned into a
promoterless EGFP vector, pd2EGFP-1 (BD Biosciences
Clontech, UK). The resulting construct was named pALB-
EGFP. Establishment of pALB-EGFP stable transfectants of
mES cells (pALB-EGFP/ES) was performed as described
previously [27]. Briefly, 1 × 107 non-differentiated mES
cells (maintained in LIF-NDESM) were transfected with
pALB-EGFP plasmid using electroporation. After electro-
poration and selection, pALB-EGFP-transfected mES
clones were harvested and screened using genomic PCR
with EGFP-specific primers. The resultant pALB-EGFP/ES
cell lines were maintained in the presence of 350 μg/ml
G418 (Gibco, UK).
Fluorescence-Activated Cell Sorting (FACS)
pALB-EGFP/ES cells were removed from culture flasks by
incubation with 0.25 mg/ml trypsin and 0.2 mg/ml EDTA
(Cambrex, UK) for 2 minutes and trypsinized to single
cell suspensions. Suspensions (containing 0.5–1 × 106
cells) were centrifuged at 13,000 g for 1 minute and pel-
lets were resuspended in 500 μl FACS buffer (PBS contain-
ing 2% (v/v) fetal bovine serum and 0.002% (w/v)
sodium azide). Populations were analyzed and sorted
using a Becton Dickinson FACstar flow cytometer and
CellQuest®  software (BD Biosciences, UK). Non-trans-
fected mES cells (ES-WT) were negative controls of the
intrinsic fluorescent intensity of the cultured mES cell
populations and defined the positive area for cell sorting.
Reverse transcriptase-polymerase chain reaction
RNA was extracted from cells using TRIZOL® (Invitrogen,
UK) or RNeasy® Mini Kit (Qiagen, UK) and was treated
with RNase-free DNase (Sigma, UK). cDNA was synthe-
sized from 1 μg of RNA using an oligo d(T)12–18 primer
(Invitrogen, UK) and M-MLV reverse transcriptase (Roche,
UK). PCR was performed using Taq DNA polymerase
(Roche, UK): 94°C for 5 minutes followed by 40 cycles of
denaturation (94°C, 1 minute), annealing (Table 1, 1
minute), extension (72°C, 2 minutes) and a final exten-
sion at 72°C for 10 minutes. Products were separated by
electrophoresis on 1% (w/v) agarose gels. All primers used
in this study (Table 1) were designed using Primer-3 out-
put program (Whitehead Institute for Biomedical
Research, 1998) and were checked by performing Basic
Local Alignment Search Tool (BLAST) within the nucle-
otide databases for mouse genome to ensure their specifi-
city.
Quantitative real-time PCR (qRT-PCR)
MJ-white 96 well plates (Bio-Rad, UK) were used for qRT-
PCR reactions. Each well contained 1–2 μl of cDNA, 5 μl
1.2 μM appropriate forward and reverse primer mix and
10 μl DyNAmo™ SYBR® Green reaction mix (FINNZYME,
Finland). The plate was sealed with Microseal 'B' clear
adhesive film (Bio-Rad, UK) to prevent the evaporation of
reactant. PCR was performed using an Opticon Monitor
qRT-PCR thermal cycler (Bio-Rad, UK): 95°C initial dena-
turation for 10 minutes followed by 40 cycles of denatur-
ation (94°C, 10 seconds), annealing (60°C, 20 seconds),
extension (72°C, 20 seconds) followed by denaturation
(76°C, 1 second). The quantity of a target gene was calcu-
lated by normalization with glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), using the following formula:
normalized target gene quantity = 2^{-[C(T) target gene/
C(T) GAPDH gene]}. The 'C(T)' value was the number of
reaction cycles required for the target gene to enter loga-
rithmic amplification. For quantification, a standard
curve for each gene was calculated from 3 dilutions of the
cDNA template by plotting the log value of the starting
concentration versus the threshold value. Primers are
specified in Table 2.
Statistical analysis
Data are presented as means ± standard error of the mean
(SEM) for the number of individual cell preparations
identified. In some cases one measurement in each exper-
iment was set at 100% as indicated in the text. All other
values were calculated relative to this. The paired Stu-
dent's t-test was used to assess the significance of differ-
ences between observed data. P < 0.05 was considered to
be statistically significant.
Abbreviations
mES: Mouse embryonic stem cell; AFP:  α-fetoprotein;
HNF: hepatocyte nuclear factor; C/EBP: CCAAT-enhancer
binding protein; G6Pase: Glucose-6-phosphatase; TAT:
tyrosine aminotransferase; Cyp3a: cytochrome P450-3a;
Pepck: phosphoenolpyruvate carboxykinase; Pou5f1:
POU domain class5 transcription factor 1; TDO: tryp-
tophan 2,3-dioxygenase; LETFs: liver-enriched transcrip-
tion factors; GFP: green fluorescent protein; FACS:
fluorescent-activated cell sorting; HIM: hepatocyte induc-
ing medium; NDESM: non-differentiated ES medium;
LIF: leukemia inhibitory factor; EBs: embryoid bodies;
pALB-EGFP/ES: pALB-EGFP-transfected mES cell line; ES-
WT: Non-transfected mES cells; qRT-PCR: Quantitative
real time PCR; GAPDH: Glyceraldehyde-3-phosphate
dehydrogenase; SEM: standard error of the mean.BMC Molecular Biology 2009, 10:35 http://www.biomedcentral.com/1471-2199/10/35
Page 11 of 11
(page number not for citation purposes)
Authors' contributions
PK carried out the experiments, performed data analysis
and participated in the sequence alignment and drafted
the manuscript. AJD designed and supervised the study
and helped to draft the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
We thank Dr. Christopher Ward (The University of Manchester) for pro-
viding us mES cell lines, Professor Richard Palmiter (University of Washing-
ton) for providing us mouse albumin promoter/enhancer DNA fragment 
and Mike Jackson (The University of Manchester) for helping us in FACS. 
This study was supported by grant from Royal Thai Government.
References
1. Bellentani S, Tiribelli C: The spectrum of liver disease in the
general population: lesson from the Dionysos study.  J Hepatol
2001, 35(4):531-537.
2. Neuberger J: Liver transplantation.  J Hepatol 2000, 32(1
Suppl):198-207.
3. Ambrosino G, Varotto S, Strom SC, Guariso G, Franchin E, Miotto D,
Caenazzo L, Basso S, Carraro P, Valente ML, et al.: Isolated hepato-
cyte transplantation for Crigler-Najjar syndrome type 1.  Cell
Transplant 2005, 14(2–3):151-157.
4. Dhawan A, Mitry RR, Hughes RD: Hepatocyte transplantation
for liver-based metabolic disorders.  J Inherit Metab Dis 2006,
29(2–3):431-435.
5. Elaut G, Henkens T, Papeleu P, Snykers S, Vinken M, Vanhaecke T,
Rogiers V: Molecular mechanisms underlying the dedifferenti-
ation process of isolated hepatocytes and their cultures.  Cur-
rent Drug Metabolism 2006, 7(6):629-660.
6. Hamazaki T, Iiboshi Y, Oka M, Papst PJ, Meacham AM, Zon LI, Terada
N:  Hepatic maturation in differentiating embryonic stem
cells in vitro.  FEBS Lett 2001, 497(1):15-19.
7. Kania G, Blyszczuk P, Jochheim A, Ott M, Wobus AM: Generation
of glycogen- and albumin-producing hepatocyte-like cells
from embryonic stem cells.  Biol Chem 2004, 385(10):943-953.
8. Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo JD, Navarro-Alvarez
N, Zhao DB, Okitsu T, Noguchi H, Basma H, Tabata Y, Chen Y, et al.:
Reversal of mouse hepatic failure using an implanted liver-
assist device containing ES cell-derived hepatocytes.  Nature
Biotechnology 2007, 25(2):254-254.
9. Yamada T, Yoshikawa M, Kanda S, Kato Y, Nakajima Y, Ishizaka S,
Tsunoda Y: In vitro differentiation of embryonic stem cells
into hepatocyte-like cells identified by cellular uptake of
indocyanine green.  Stem Cells 2002, 20(2):146-154.
10. Zaret KS: Regulatory phases of early liver development: par-
adigms of organogenesis.  Nat Rev Genet 2002, 3(7):499-512.
11. Tilghman SM, Belayew A: Transcriptional Control of the Murine
Albumin Alpha-Fetoprotein Locus During Development.
Proceedings of the National Academy of Sciences of the United States of
America-Biological Sciences 1982, 79(17):5254-5257.
12. Haber BA, Chin S, Chuang E, Buikhuisen W, Naji A, Taub R: High-
Levels of Glucose-6-Phosphatase Gene and Protein Expres-
sion Reflect an Adaptive Response in Proliferating Liver and
Diabetes.  Journal of Clinical Investigation 1995, 95(2):832-841.
13. Nagao M, Nakamura T, Ichihara A: Developmental Control of
Gene-Expression of Tryptophan 2,3-Dioxygenase in Neona-
tal Rat-Liver.  Biochimica Et Biophysica Acta 1986, 867(4):179-186.
14. Noda C, Fukushima C, Fujiwara T, Matsuda K, Kobune Y, Ichihara A:
Developmental Regulation of Rat Serine Dehydratase Gene-
Expression – Evidence for the Presence of a Repressor in
Fetal Hepatocytes.  Biochimica Et Biophysica Acta-Gene Structure and
Expression 1994, 1217(2):163-173.
15. Schrem H, Klempnauer J, Borlak J: Liver-enriched transcription
factors in liver function and development. Part I: The hepa-
tocyte nuclear factor network and liver-specific gene expres-
sion.  Pharmacological Reviews 2002, 54(1):129-158.
16. Schrem H, Klempnauer J, Borlak J: Liver-enriched transcription
factors in liver function and development. Part II: the C/
EBPs and D site-binding protein in cell cycle control, carcino-
genesis, circadian gene regulation, liver regeneration, apop-
tosis, and liver-specific gene regulation.  Pharmacological Reviews
2004, 56(2):291-330.
17. Kamiya A, Gonzalez FJ, Nakauchi H: Identification and differenti-
ation of hepatic stem cells during liver development.  Front
Biosci 2006, 11:1302-1310.
18. Shiojiri N, Lemire JM, Fausto N: Cell lineages and oval cell pro-
genitors in rat liver development.  Cancer Res 1991,
51(10):2611-2620.
19. Greengard O: The developmental formation of enzymes in rat
liver.  New York: Academic Press; 1970. 
20. Miyashita H, Suzuki A, Fukao K, Nakauchi H, Taniguchi H: Evidence
for hepatocyte differentiation from embryonic stem cells in
vitro.  Cell Transplant 2002, 11(5):429-434.
21. Chinzei R, Tanaka Y, Shimizu-Saito K, Hara Y, Kakinuma S, Watanabe
M, Teramoto K, Arii S, Takase K, Sato C, et al.: Embryoid-body
cells derived from a mouse embryonic stem cell line show
differentiation into functional hepatocytes.  Hepatology 2002,
36(1):22-29.
22. Lauss M, Stary M, Tischler J, Egger G, Puz S, Bader-Allmer A, Seiser
C, Weitzer G: Single inner cell masses yield embryonic stem
cell lines differing in lifr expression and their developmental
potential.  Biochem Biophys Res Commun 2005, 331(4):1577-1586.
23. Ward CM, Barow KM, Stern PL: Significant variations in differ-
entiation properties between independent mouse ES cell
lines cultured under defined conditions.  Experimental Cell
Research 2004, 293(2):229-238.
24. Sharova LV, Sharov AA, Piao Y, Shaik N, Sullivan T, Stewart CL,
Hogan BL, Ko MS: Global gene expression profiling reveals sim-
ilarities and differences among mouse pluripotent stem cells
of different origins and strains.  Dev Biol 2007, 307(2):446-459.
25. Hu AB, Cai JY, Zheng QC, He XQ, Shan Y, Pan YL, Zeng GC, Hong
A, Dai Y, Li LS: High-ratio differentiation of embryonic stem
cells into hepatocytes in vitro.  Liver Int 2004, 24(3):237-245.
26. Ishii T, Yasuchika K, Fujii H, Hoppo T, Baba S, Naito M, Machimoto T,
Kamo N, Suemori H, Nakatsuji N, et al.: In vitro differentiation
and maturation of mouse embryonic stem cells into hepato-
cytes.  Exp Cell Res 2005, 309(1):68-77.
27. Yamamoto Y, Teratani T, Yamamoto H, Quinn G, Murata S, Ikeda R,
Kinoshita K, Matsubara K, Kato T, Ochiya T: Recapitulation of in
vivo gene expression during hepatic differentiation from
murine embryonic stem cells.  Hepatology 2005, 42(3):558-567.
28. Jochheim A, Hillemann T, Kania G, Scharf J, Attaran M, Manns MP,
Wobus AM, Ott M: Quantitative gene expression profiling
reveals a fetal hepatic phenotype of murine ES-derived hepa-
tocytes.  Int J Dev Biol 2004, 48(1):23-29.
29. Darlington GJ: Molecular mechanisms of liver development
and differentiation.  Current Opinion in Cell Biology 1999,
11(6):678-682.
30. Flodby P, Barlow C, Kylefjord H, Ahrlund-Richter L, Xanthopoulos
KG: Increased hepatic cell proliferation and lung abnormali-
ties in mice deficient in CCAAT/enhancer binding protein
alpha.  Journal of Biological Chemistry 1996, 271(40):24753-24760.
31. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde
MD, Taylor LR, Wilson DR, Darlington GJ: Impaired Energy
Homeostasis in C/Ebp-Alpha Knockout Mice.  Science 1995,
269(5227):1108-1112.
32. Pinkert CA, Ornitz DM, Brinster RL, Palmiter RD: An albumin
enhancer located 10 kb upstream functions along with its
promoter to direct efficient, liver-specific expression in
transgenic mice.  Genes Dev 1987, 1(3):268-276.